ESC 365 - Optimizing SGLT2 inhibition: recent data.

Open Access

Optimizing SGLT2 inhibition: recent data.

Session: Unleashing the full potential of SGLT2 inhibition in heart failure: optimizing patient benefit in clinical practice

Topic: Heart Failure

Speaker: Professor S. Anker (Berlin, DE) Professor A. Stewart Coats (Sydney, AU)

Sponsored by Charité Berlin - Supported by an unrestricted educational grant from Boehringer Ingelheim

Event: Heart Failure 2021

Congress Presentation

Add to my library

About the speakers

Professor Stefan Anker

Charite University Hospital, Berlin (Germany)

180 presentations

16 followers

Professor Andrew Stewart Coats

Heart Research Institute, Sydney (Australia)

113 presentations

23 followers

4 more presentations in this session

Welcome and introduction.

Speaker: Professor I. Pina (Philadelphia, US)

Optimizing treatment initiation: time matters.

Speaker: Professor J. Butler (Dallas, US) Professor M. Packer (Dallas, US)

Live Q&A.

Conclusion.

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Access the full session

Unleashing the full potential of SGLT2 inhibition in heart failure: optimizing patient benefit in clinical practice

Speakers: Professor S. Anker, Professor A. Stewart Coats, Professor I. Pina, Professor J. Butler, Professor M. Packer...

About the event

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources